Bone Health in Patients With Atopic Dermatitis
NCT03800004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-02-10
Summary
This study examines the bone health in children with atopic dermatitis
Conditions
Sponsors & Collaborators
-
Pediatric Dermatology Research Alliance
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Megha M Tollefson, MD · Mayo Clinic
-
Henry Nguyen, MD · Mayo Clinic
Eligibility
- Min Age
- 5 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-30
- Primary Completion
- 2024-07-16
- Completion
- 2024-07-16
Countries
- United States
Study Locations
More Related Trials
-
China Atopic Dermatitis Registry Study
NCT05023668 ·Status: UNKNOWN
-
Treatment of Nighttime Pruritus in Atopic Dermatitis
NCT03688464 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis
NCT05200403 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
NCT03849716 ·Status: ACTIVE_NOT_RECRUITING
-
A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
NCT05571943 ·Status: COMPLETED ·Phase: PHASE3
-
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
NCT00001760 ·Status: COMPLETED
-
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803 ·Status: RECRUITING
-
Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis
NCT00310492 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
NCT01756898 ·Status: COMPLETED ·Phase: PHASE2
-
Staphylococcus Aureus in Atopic Dermatitis Immunopathology
NCT04715087 ·Status: COMPLETED ·Phase: NA
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
Atopy Patch Test in Children With Atopic Dermatitis
NCT02552979 ·Status: COMPLETED
-
A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)
NCT04220411 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
NCT06807268 ·Status: RECRUITING ·Phase: PHASE3
-
IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
NCT05372003 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
NCT04717310 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
NCT05139836 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients
NCT04352595 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Hemay005 in Adult With Atopic Dermatitis
NCT05769946 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis
NCT01675232 ·Status: COMPLETED ·Phase: NA
-
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
NCT05399368 ·Status: TERMINATED ·Phase: PHASE2
-
Atopic Dermatitis (AD) and Food Allergy
NCT03168113 ·Status: COMPLETED
-
Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone
NCT04154033 ·Status: WITHDRAWN ·Phase: PHASE2
-
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
NCT01782703 ·Status: ACTIVE_NOT_RECRUITING